Repaglinide and exercise rehabilitation effective combo for treating diabetes

Results:

All eligible patients showed similar pretreatment fasting blood glucose, glycosylated haemoglobin, and 2 h postprandial blood glucose (P > 0.05). After treatment, repaglinide plus exercise rehabilitation resulted in lower levels of fasting blood glucose, glycosylated haemoglobin, and 2 h postprandial blood glucose versus repaglinide alone (P < 0.05). Repaglinide plus exercise rehabilitation was associated with a significantly shorter time to normal blood glucose and a milder fluctuation versus repaglinide (P < 0.05). The incidence of adverse reactions and blood glucose adequate rate was 6% and 94% in the experimental group and 50% and 52% in the control group, respectively (P < 0.05).

Thus, Repaglinide plus exercise rehabilitation results in effective blood glucose control and reduced incidence of adverse reactions and yields a promising efficacy, so it is worthy of clinical promotion and application.

Reference:

Clinical Effects of Exercise Rehabilitation Combined with Repaglinide in the Treatment of Diabetes by Yan Li et al. published in the Disease Markers.

https://pubmed.ncbi.nlm.nih.gov/35371345/

Keywords:

Yan Li, Xi Wang, Ying Zhang, Clinical Effects, Exercise Rehabilitation, Combination, Repaglinide, Treatment of Diabetes, Disease Markers, adverse reactions, blood glucose control, efficacy, fasting blood glucose